A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin–0.1% dexamethasone combination compared to 1% azithromycin alone, dexamethasone 0.1% alone, and vehicle in the treatment of subjects with blepharitis

A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin–0.1% dexamethasone combination compared to 1% azithromycin alone, dexamethasone 0.1% alone, and vehicle in the treatment of subjects with blepharitis

Kamran Hosseini,1 Richard L Lindstrom,2,3 Gary Foulks,4 Kelly K Nichols5 1InSite Vision, Alameda, CA, 2Minnesota Eye Consultants, 3Department of Ophthalmology and Visual Neurosciences, University of Minnesota Medical School, Minneapolis, MN, 4Department of Ophthalmology and Vision Science, School o...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hosseini K, Lindstrom RL, Foulks G, Nichols KK
Format: article
Langue:EN
Publié: Dove Medical Press 2016
Sujets:
blepharitis
dexamethasone
azithromycin
DuraSite
Ophthalmology
RE1-994
Accès en ligne:https://doaj.org/article/a01d9c0fb50c4a5685986f2d35951ed0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/a01d9c0fb50c4a5685986f2d35951ed0

Documents similaires